＝＝＝2016 年＝＝＝
1. 小坂浩隆
統合失調症と自閉スペクトラム症

精神科, 29: 381-389, 2016.11
2. Goto T, Ishitobi M, Takahashi T, Higashima M, Wada Y.
Reversible Splenial Lesion Related to Acute Lithium Intoxication in a Bipolar Patient: A Case
Report.

J Clin Psychopharmacol, 36(5): 528-9, 2016.10 doi: 10.1097/JCP.0000000000000544.
3. Kosaka H, Okamoto Y, Munesue T, Yamasue H, Inohara K, Fujioka T, Anme T, Orisaka M, Ishitobi M,Jung M, Fujisawa TX, Tanaka S, Arai S, Asano M, Saito DN, Sadato N, Tomoda A, Omori M, Sato M,Okazawa H, Higashida H, Wada Y.
Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults withhigh-functioning autism: a 24-week randomized clinical trial.

Translational Psychiatry, 6(8): e872, 2016.8 doi: 10.1038/tp.2016.152
4. 高岡健、岡田俊、小坂浩隆、野間俊一、森岡由起子、吉川 徹
委員会報告児童青年精神医学用語集 2016 年版の刊行について

児童青年精神医学とその近接領域, 57(4): 628-664, 2016.8
5. Komeda H, Osanai H, Yanaoka K, Okamoto Y, Fujioka T, Arai S, Inohara K, Koyasu M, Kusumi T,Takiguchi S, Kawatani M, Kumazaki H, Hiratani M, Tomoda A, Kosaka H.
Decision making processes based on social conventional rules in early adolescents with andwithout autism spectrum disorders.

Scientific Reports, 6: 37875, 2016.7 doi: 10.1038/srep37875
6. Morita T, Kosaka H, Saito DN, Fujii T, Ishitobi M, Munesue T, Inohara K, Okazawa H, Kakigi R,Sadato N.
Neural correlates of emotion processing during observed self-face recognition in individuals withautism spectrum disorders.

Research in Autism Spectrum Disorders, 26: 16-32, 2016.6 doi: 10.1371/journal.pone.0136427.
7. Arai S, Okamoto Y, Fujioka T, Inohara K, Ishitobi M, Matusmura Y, Jung M, Kawamura K, Takiguchi
S, Tomoda A, Wada Y, Hiratani M, Matsuura N, Kosaka H (Corresponding Author).
Altered frontal pole development affects self-generated spatial working memory in ADHD.

BRAIN & DEVELOPMENT, 38(5): 471-480, 2016.6 doi: 10.1016/j.braindev.2015.11.005.
8. Okamoto Y, Ishitobi M, Wada Y, Kosaka H.
The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders.

CNS & Neurological Disorders-Drug Targets, 15: 564-577, 2016.6 doi:
10.2174/1871527315666160413120845
9. 石飛信、丁ミンヨン、小坂浩隆
自閉スペクトラム症の原因はわかったの？ ?脳画像研究の観点から?

チャイルドヘルス, 19(5): 18-22, 2016.5
10. 小坂浩隆、岡本悠子
発達障害の新しい治療法 ～オキシトシンを中心に～

チャイルドヘルス, 19(5): 27-32, 2016.5
11. 丁ミンヨン、小坂浩隆
自閉症スペクトラムのデフォルトモードネットワークと臨床応用

Clinical Neuroscience, 34(6): 717-720, 2016.5
12. 石飛信、小坂浩隆、神尾陽子
自閉スペクトラム症の精神科的併存症に対する出口を見据えた薬物療法

精神保健研究, 62: 67-71, 2016.3
13. Fujioka T, Inohara K, Okamoto Y, Masuya Y, Ishitobi M, Saito DN, Jung M, Arai S, Matsumura Y,Fujisawa TX, Narita K, Suzuki K, Tsuchiya KJ, Mori N, Katayama T, Sato M, Munesue T, Okazawa H,Tomoda A, Wada Y, Kosaka H (Corresponding Author).
Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorderand typical development in male adolescents and adults.

Molecular Autism, 7: 19, 2016.3 doi: 10.1186/s13229-016-0083-y.
14. Fujioka T, Takiguchi S, Yatsuga C, Hiratani M, Hong KEM, Shin MS, Cho S, Kosaka H, Tomoda A.
Advanced test of attention in children with attention-deficit/hyperactivity disorder in Japan forevaluation of methylphenidate and atomoxetine effects.

Clinical Psychopharmacology and Neuroscience, 14(1): 79-87, 2016.2 doi: 10.9758/cpn.2016.14.1.79.
15. 小坂浩隆
注意欠如多動症

臨床精神薬理, 19(3): 295-306, 2016.2
16. 岡沢秀彦、小坂浩隆
自閉スペクトラム症者の共感性

心理学評論, 58(3): 389-391, 2016.2
17. 大森晶夫、小坂浩隆
老年期うつ病と認知症の見分け方

臨床老年看護, 23(1): 2-11, 2016.1

18. Munesue T, Nakamura H, Kikuchi M, Miura Y, Takeuchi N, Anme T, Nanba E, Adachi K, Tsubouchi K,Sai Y, Miyamoto K, Horike S, Yokoyama S, Nakatani H, Kosaka H, Minabe Y, Higashida H.
Oxytocin for male subjects with autism spectrum disorder and comorbid intellectual disabilities:
A randomized pilot study.

Frontiers in Psychiatry, 7: 2, 2016.1 doi: 10.3389/fpsyt.2016.00002.
19. Kumazaki H, Muramatsu T, Fujisawa TX, Miyao M, Matsuura E, Okada K, Kosaka H, Tomoda A, Mimura M.
Assessment of olfactory detection thresholds in children with autism spectrum disorders using apulse ejection system.

Molecular Autism, 7: 6, 2016.1 doi: 10.1186/s13229-016-0071-2.